Among the three opinions arriving on Thursday from the April argument session was Hikma Pharmaceuticals USA v. Amarin Pharma.

The Supreme Court ruled that a knockoff version of Amarin’s Vascepa didn’t infringe on patents — a decision with far-reaching ...

(The Center Square) - The U.S. Supreme Court, in a unanimous decision on Thursday, ruled that a cardiovascular drugmaker did ...

In a decision that crossed the ideological divide of the nation’s highest court, all six conservative justices joined Justice ...

With a resounding unanimous vote, the U.S. Supreme Court has sided with Hikma Pharmaceuticals, ruling that its generic ...

By Blake Brittain WASHINGTON, June 4 (Reuters) - The U.S. Supreme Court ruled on Thursday drugmaker Hikma's generic version ...

Amarin's blockbuster hopes for fish oil derivative Vascepa came to a crashing halt in March after a district judge struck down its key patents, just months after a major new FDA approval. Amarin put ...

Amarin Corporation PLC AMRN reported first-quarter 2022 adjusted loss of 6 cents (excluding stock-based compensation) per American depositary share against adjusted earnings of 3 cents in the year-ago ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Vascepa is an omega-3 fatty acid also known as icosapent ethyl. Doctors prescribe it to adults with certain conditions to lower their blood triglyceride levels and help reduce the risk of heart ...